Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03107013

A Study to Investigate the Mass Balance of BTD-001 — HV103  

Molecular Mechanisms of Pharmacological Action Clinical Trial

Official title:
An Open Label, Single-Dose, Single-Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BTD-001 in Healthy Male Subjects

Clinical Trial Summary

This is a single-centre, open-label, non-randomised, single oral dose study in healthy male subjects to assess the mass balance recovery of carbon-14 (14C)-BTD-001.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Molecular Mechanisms of Pharmacological Action
Clinical Trial Details
NCT number NCT03107013
Study type Interventional
Source Balance Therapeutics
Contact
Status Completed
Phase Phase 1
Start date April 3, 2017
Completion date May 1, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Recruiting NCT04518852 - TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC Phase 2
Recruiting NCT04169230 - Citalopram and Self Emotional Processing N/A
Terminated NCT04489420 - Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM Phase 1
Completed NCT03841292 - Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence N/A
Recruiting NCT04556071 - Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer Phase 2
Completed NCT03403777 - Avelumab in Refractory Testicular Germ Cell Cancer. Phase 2
Recruiting NCT03655847 - Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection Phase 4
Not yet recruiting NCT03889626 - The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer Phase 3
Not yet recruiting NCT06462196 - Natural History of Depression, Bipolar Disorder and Suicide Risk
Not yet recruiting NCT05375240 - Propranolol on Post Stroke Immune Status and Infection Phase 2
Completed NCT03572790 - Effects of Seven Day Prucalopride Administration in Healthy Volunteers N/A
Completed NCT04922593 - Relative Bioavailability of LY03010 Compared to Listed Drug Phase 1
Completed NCT03863366 - Effects of Acute Prucalopride Administration in Healthy Volunteers N/A
Not yet recruiting NCT05465031 - Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Phase 4
Recruiting NCT05657860 - Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome Phase 4
Recruiting NCT04289142 - Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients Phase 4
Recruiting NCT04161404 - Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition Phase 1